Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.31 trillion and total revenue of $117.28 billion.
Market Cap
1.31T
Revenue
117.28B
Profits
-36.66B
PE Ratio
n/a
Profit Margin
-31.25%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.89B | 1.96% | 86,474 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 88.33B | 3.31% | 768,758 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 82.41B | 1.48% | 26,507 | 15.53B |
| 4 | ARGX | argenx SE | 56.23B | 1.26% | 7,977 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 42.55B | 0.24% | 13,547 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.45B | - | 18,454 | - |
| 7 | RPRX | Royalty Pharma plc | 37.94B | 1.80% | 100,295 | 2.54B |
| 8 | GMAB | Genmab A/S | 34.43B | -0.11% | 915,456 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.30B | 1.86% | 110,866 | 7.53M |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 26.18B | -15.80% | 434,956 | 4.80B |
| 11 | INSM | Insmed Incorporated | 23.57B | 11.27% | 1,448,860 | 1.14B |
| 12 | INCY | Incyte Corporation | 23.49B | -0.83% | 135,466 | 6.01B |
| 13 | BNTX | BioNTech SE | 22.47B | 1.65% | 17,777 | 3.03B |
| 14 | EXEL | Exelixis, Inc. | 16.61B | 1.13% | 32,459 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 16.48B | 0.58% | 5,859 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.82B | 0.41% | 173,132 | 1.66B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.04B | 1.38% | 57,626 | 713.07M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 13.44B | 0.99% | 14,538 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.72B | 0.89% | 71,173 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | 0.01% | 87,137 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.92B | 0.71% | 19,945 | 3.41B |
| 22 | TWST | Twist Bioscience Corporation | 10.86B | -0.13% | 89,229 | 431.80M |
| 23 | KYMR | Kymera Therapeutics, Inc. | 10.39B | 2.03% | 25,378 | 105.00M |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.07B | 1.08% | 9,244 | 1.28B |
| 25 | CAI | Caris Life Sciences, Inc. | 10.06B | 0.41% | 71,157 | 989.61M |
| 26 | PCVX | Vaxcyte, Inc. | 9.92B | 2.51% | 10,778 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 9.65B | 1.42% | 3,014 | 440.48M |
| 28 | IBRX | ImmunityBio, Inc. | 9.43B | 1.02% | 366,180 | 165.79M |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.33B | - | 10,716 | 830.81M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.32B | 1.32% | 9,001 | 281.99M |
| 31 | SYRE | Spyre Therapeutics, Inc. | 9.30B | -0.24% | 64,137 | - |
| 32 | CYTK | Cytokinetics, Incorporated | 8.69B | 1.96% | 20,306 | 67.67M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.65B | 1.74% | 20,356 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 8.19B | 0.64% | 38,242 | 799.54M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.01B | 0.53% | 5,801 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.92B | 0.90% | 173,833 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 7.67B | 2.09% | 14,469 | 776.57M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.60B | 1.87% | 72,724 | 874.09M |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.37B | 0.26% | 16,214 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.34B | 0.04% | 8,731 | 239.92M |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.22B | -2.17% | 4,366 | 290.54M |
| 42 | IMVT | Immunovant, Inc. | 6.20B | 1.97% | 33,416 | - |
| 43 | KOD | Kodiak Sciences Inc. | 6.18B | 1.50% | 27,693 | - |
| 44 | BLTE | Belite Bio, Inc | 6.02B | 0.58% | 4,942 | - |
| 45 | MANE | Veradermics, Incorporated | 5.94B | -1.20% | 7,704 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.73B | 2.36% | 41,978 | - |
| 47 | CGON | CG Oncology, Inc. | 5.67B | - | 4,911 | 6.23M |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | - | 5,058 | 618.07M |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.41B | 2.66% | 16,629 | - |
| 50 | CRSP | CRISPR Therapeutics AG | 5.37B | 2.57% | 118,970 | 13.39M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.33B | 1.25% | 24,212 | 1.01B |
| 52 | ERAS | Erasca, Inc. | 5.27B | -0.26% | 49,588 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.22B | 1.99% | 52,300 | - |
| 54 | IOVA | Iovance Biotherapeutics, Inc. | 5.10B | -24.04% | 13,696,675 | 324.97M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.67B | -2.55% | 18,420 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | 0.23% | 10,187 | 1.90M |
| 57 | ABCL | AbCellera Biologics Inc. | 4.45B | 0.73% | 163,920 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.40B | 0.02% | 15,927 | - |
| 59 | LEGN | Legend Biotech Corporation | 4.38B | 0.40% | 33,014 | 1.27B |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.38B | 1.57% | 36,683 | 10.35M |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.99B | 0.95% | 101,586 | 463.98M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.79B | 1.13% | 22,949 | 53.81M |
| 63 | IRON | Disc Medicine, Inc. | 3.67B | -0.66% | 8,380 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.63B | 3.03% | 63,619 | 7.50M |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.57B | 1.82% | 74,490 | 1.14B |
| 66 | CELC | Celcuity Inc. | 3.50B | 2.92% | 34,520 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.49B | 0.21% | 6,382 | 148.00K |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.33B | 1.55% | 9,672 | - |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.32B | 3.02% | 18,676 | 890.79M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.29B | 0.29% | 12,853 | 234.13M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.23B | 1.97% | 27,030 | - |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.23B | 2.01% | 11,189 | 606.33M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.12B | 1.09% | 26,629 | 3.60M |
| 74 | NRIX | Nurix Therapeutics, Inc. | 3.01B | 1.14% | 44,407 | 701.94M |
| 75 | VKTX | Viking Therapeutics, Inc. | 2.98B | 0.77% | 398,660 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.94B | 2.26% | 127,500 | 156.04M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.77B | 0.74% | 98,080 | 71.13M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.69B | 1.69% | 50,493 | 117.00M |
| 79 | RXRX | Recursion Pharmaceuticals, Inc. | 2.68B | 2.99% | 1,623,752 | 54.86M |
| 80 | MBX | MBX Biosciences, Inc. | 2.64B | 1.37% | 4,829 | - |
| 81 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | 2.52% | 8,239 | 7.12M |
| 82 | ADMA | ADMA Biologics, Inc. | 2.56B | 1.42% | 49,746 | 512.28M |
| 83 | ZLAB | Zai Lab Limited | 2.53B | -2.37% | 60,927 | 449.61M |
| 84 | MESO | Mesoblast Limited | 2.49B | 17.18% | 106,722 | 120.25M |
| 85 | BHVN | Biohaven Ltd. | 2.37B | 0.97% | 25,879 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.34B | 0.61% | 18,977 | 158.00K |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.33B | 0.92% | 33,285 | 311.51M |
| 88 | PHVS | Pharvaris N.V. | 2.30B | - | 7,613 | - |
| 89 | VERA | Vera Therapeutics, Inc. | 2.29B | 2.81% | 25,885 | - |
| 90 | AGIO | Agios Pharmaceuticals, Inc. | 2.29B | 0.58% | 18,666 | 98.34M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | 1.25% | 24,267 | 959.90M |
| 92 | XNCR | Xencor, Inc. | 2.25B | 1.10% | 37,085 | 104.97M |
| 93 | PGEN | Precigen, Inc. | 2.22B | 1.97% | 247,448 | 85.72M |
| 94 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 4.28% | 19,282 | - |
| 95 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.20B | -0.35% | 17,258 | 208.78M |
| 96 | FTRE | Fortrea Holdings Inc. | 2.18B | -11.48% | 166,586 | 2.67B |
| 97 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | 3.76% | 454,470 | - |
| 98 | IMNM | Immunome, Inc. | 2.17B | 1.71% | 18,180 | 4.02M |
| 99 | VCEL | Vericel Corporation | 2.16B | 2.51% | 11,085 | 306.30M |
| 100 | ABSI | Absci Corporation | 2.11B | 3.62% | 396,572 | 1.56M |
| 101 | SEPN | Septerna, Inc. | 2.11B | 2.17% | 5,124 | 98.88M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 2.07B | 1.66% | 55,833 | 1.97B |
| 103 | ZYME | Zymeworks Inc. | 2.07B | 0.90% | 23,439 | 37.13M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 2.05B | 0.72% | 10,681 | 1.13B |
| 105 | GENB | Generate Biomedicines, Inc. | 2.04B | 3.58% | 85,251 | 26.48M |
| 106 | VIR | Vir Biotechnology, Inc. | 2.02B | 0.17% | 69,038 | 303.23M |
| 107 | ADRX | ADARx Pharmaceuticals, Inc. | 2.01B | - | 3,766 | 6.13M |
| 108 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.63% | 24,988 | - |
| 109 | TRAX | First Tracks Biotherapeutics, Inc. | 1.93B | 0.50% | 11,020 | - |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.93B | 3.23% | 219,935 | 59.51M |
| 111 | MLYS | Mineralys Therapeutics, Inc. | 1.92B | 1.45% | 84,020 | - |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.88B | - | 3,044 | 1.00M |
| 113 | COAG | Hemab Therapeutics Holdings, Inc. | 1.81B | 0.65% | 4,806 | - |
| 114 | MAZE | Maze Therapeutics, Inc. | 1.79B | 1.45% | 5,127 | 20.00M |
| 115 | KLRA | Kailera Therapeutics, Inc. | 1.77B | 1.94% | 21,248 | - |
| 116 | QURE | uniQure N.V. | 1.77B | 1.92% | 76,127 | 18.67M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.76B | -0.97% | 2,485 | - |
| 118 | STOK | Stoke Therapeutics, Inc. | 1.74B | 1.93% | 7,787 | 27.59M |
| 119 | NVAX | Novavax, Inc. | 1.72B | 1.16% | 91,724 | 413.80M |
| 120 | RARE | Ultragenyx Pharmaceutical Inc. | 1.72B | 1.74% | 78,283 | 717.00M |
| 121 | NBTX | Nanobiotix S.A. | 1.69B | -1.47% | 915 | 13.15M |
| 122 | IMCR | Immunocore Holdings plc | 1.66B | -0.87% | 26,129 | 430.78M |
| 123 | URGN | UroGen Pharma Ltd. | 1.66B | 0.76% | 20,151 | 188.73M |
| 124 | NUVB | Nuvation Bio Inc. | 1.64B | 1.96% | 85,567 | 169.90M |
| 125 | OCUL | Ocular Therapeutix, Inc. | 1.64B | 2.19% | 50,828 | 52.06M |
| 126 | REPL | Replimune Group, Inc. | 1.58B | 4.30% | 98,809 | - |
| 127 | GPCR | Structure Therapeutics Inc. | 1.55B | 1.02% | 15,145 | - |
| 128 | INVA | Innoviva, Inc. | 1.55B | 1.30% | 8,331 | 440.00M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.53B | 2.11% | 2,618 | - |
| 130 | ANAB | AnaptysBio, Inc. | 1.51B | -0.01% | 4,541 | 106.09M |
| 131 | LYCA | Lycia Therapeutics, Inc. | 1.50B | 3.75% | 1,209 | 4.44M |
| 132 | GHRS | GH Research PLC | 1.42B | - | 6,391 | - |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 3.07% | 49,961 | 5.49M |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.36B | 2.27% | 5,273 | - |
| 135 | KRSA | Korsana Biosciences, Inc. | 1.34B | -2.49% | 2,231 | - |
| 136 | AAPG | Ascentage Pharma Group International | 1.32B | -0.03% | 3,894 | 94.61M |
| 137 | NKTR | Nektar Therapeutics | 1.31B | -0.78% | 17,991 | 54.59M |
| 138 | SVRA | Savara Inc. | 1.30B | 1.79% | 36,709 | - |
| 139 | OMER | Omeros Corporation | 1.29B | -0.06% | 48,127 | 38.42M |
| 140 | SNDX | Syndax Pharmaceuticals, Inc. | 1.29B | 1.15% | 33,062 | 252.25M |
| 141 | LBRX | LB Pharmaceuticals Inc | 1.28B | - | 30,615 | - |
| 142 | KARD | Kardigan, Inc. | 1.28B | - | 6,827 | - |
| 143 | VOR | Vor Biopharma Inc. | 1.24B | 1.69% | 35,190 | - |
| 144 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -0.56% | 16,962 | - |
| 145 | VSTM | Verastem, Inc. | 1.21B | 1.58% | 55,207 | 87.53M |
| 146 | SLN | Silence Therapeutics plc | 1.19B | 0.05% | 16,704 | 615.00K |
| 147 | MNKD | MannKind Corporation | 1.14B | 2.92% | 91,987 | 393.63M |
| 148 | JANX | Janux Therapeutics, Inc. | 1.13B | 2.44% | 9,398 | 24.00M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.13B | -1.24% | 1,934 | - |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 2.60% | 674 | - |
| 151 | RAPP | Rapport Therapeutics, Inc. | 1.11B | 2.67% | 51,477 | 20.00M |
| 152 | SGP | SpyGlass Pharma, Inc. | 1.10B | - | 568 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.09B | 1.43% | 6,979 | 1.30M |
| 154 | CTY | City Therapeutics, Inc. | 1.08B | - | 1,493 | 14.34M |
| 155 | MLTX | MoonLake Immunotherapeutics | 1.06B | 1.14% | 17,084 | - |
| 156 | LTGO | Latigo Biotherapeutics, Inc. | 1.05B | - | 1,279 | - |
| 157 | IMTX | Immatics N.V. | 1.02B | 1.36% | 7,649 | 47.65M |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 0.90% | 12,423 | - |
| 159 | PRME | Prime Medicine, Inc. | 994.49M | 4.29% | 353,266 | 4.07M |
| 160 | KURA | Kura Oncology, Inc. | 971.45M | 1.87% | 158,844 | 77.23M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 970.71M | 0.70% | 15,062 | - |
| 162 | RIGL | Rigel Pharmaceuticals, Inc. | 957.34M | 1.01% | 5,794 | 276.79M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 953.80M | 3.04% | 13,494 | 28.73M |
| 164 | MGTX | MeiraGTx Holdings plc | 952.75M | 1.74% | 10,213 | 397.50M |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 936.33M | - | 3,934 | 99.00K |
| 166 | AKTS | Aktis Oncology, Inc. | 935.52M | - | 2,202 | 10.06M |
| 167 | JBIO | Jade Biosciences, Inc. | 931.07M | 0.34% | 84,075 | - |
| 168 | ALMS | Alumis Inc. | 918.99M | -0.42% | 19,798 | 7.40M |
| 169 | DNA | Ginkgo Bioworks Holdings, Inc. | 917.85M | 2.33% | 131,049 | 132.42M |
| 170 | ANRO | Alto Neuroscience, Inc. | 915.52M | - | 4,816 | - |
| 171 | CRVS | Corvus Pharmaceuticals, Inc. | 901.78M | 1.90% | 13,193 | - |
| 172 | IVA | Inventiva S.A. | 883.12M | 1.62% | 86,150 | 2.81M |
| 173 | OBX | Obsidian Therapeutics, Inc. | 877.17M | -2.67% | 6,408 | - |
| 174 | ABUS | Arbutus Biopharma Corporation | 862.62M | 0.93% | 24,651 | 181.72M |
| 175 | PHAR | Pharming Group N.V. | 853.09M | -0.65% | 1,470 | 386.75M |
| 176 | SANA | Sana Biotechnology, Inc. | 811.27M | 3.04% | 76,442 | - |
| 177 | HELP | Helus Pharma Inc. | 803.66M | 0.82% | 42,465 | - |
| 178 | APMD | Apnimed, Inc. | 797.23M | - | 7,584 | 115.12M |
| 179 | ARDX | Ardelyx, Inc. | 784.94M | 1.61% | 62,090 | 450.89M |
| 180 | AVBP | ArriVent BioPharma, Inc. | 781.03M | 0.70% | 9,863 | - |
| 181 | OABI | OmniAb, Inc. | 777.84M | 1.33% | 44,158 | 38.46M |
| 182 | ANNX | Annexon, Inc. | 777.27M | 1.49% | 46,383 | - |
| 183 | SGMT | Sagimet Biosciences Inc. | 767.94M | 0.84% | 33,487 | - |
| 184 | WVE | Wave Life Sciences, Inc. | 733.69M | 2.20% | 183,628 | 70.92M |
| 185 | FDMT | 4D Molecular Therapeutics, Inc. | 723.15M | 1.24% | 12,879 | 92.01M |
| 186 | ATTO | Attovia Therapeutics, Inc. | 719.46M | -0.25% | 6,253 | 1.80M |
| 187 | ACHV | Achieve Life Sciences, Inc. | 714.14M | 1.31% | 8,452 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 707.25M | -5.92% | 22,726 | 109.82M |
| 189 | IAM | Iambic Therapeutics, Inc. | 699.16M | -0.20% | 12,640 | 18.25M |
| 190 | DSGN | Design Therapeutics, Inc. | 694.66M | 0.18% | 4,581 | - |
| 191 | SLBT | SL Science Holding Limited | 690.02M | - | 678 | 3.27M |
| 192 | IMMX | Immix Biopharma, Inc. | 685.61M | 1.78% | 33,813 | - |
| 193 | CADL | Candel Therapeutics, Inc. | 684.84M | 3.23% | 13,519 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 676.33M | 2.36% | 29,591 | 41.47M |
| 195 | SLDB | Solid Biosciences Inc. | 675.52M | -2.78% | 12,129 | - |
| 196 | AURA | Aura Biosciences, Inc. | 663.71M | - | 62,813 | - |
| 197 | OLMA | Olema Pharmaceuticals, Inc. | 660.61M | 0.80% | 42,241 | - |
| 198 | ANL | Adlai Nortye Group Ltd. | 656.86M | - | 2,733 | 18.06M |
| 199 | BCAX | Bicara Therapeutics Inc. | 647.50M | 0.26% | 172,858 | - |
| 200 | CRMD | CorMedix Inc. | 631.35M | -1.22% | 50,962 | 462.25M |
| 201 | GERN | Geron Corporation | 626.41M | 0.67% | 301,992 | 204.56M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 622.34M | 1.65% | 11,306 | 136.07M |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 618.39M | 0.76% | 78,866 | 8.22M |
| 204 | NGNE | Neurogene Inc. | 614.75M | 0.99% | 8,226 | 925.00K |
| 205 | NVCT | Nuvectis Pharma, Inc. | 598.20M | - | 1,345 | - |
| 206 | CLYM | Climb Bio, Inc. | 591.59M | 1.78% | 12,133 | - |
| 207 | STTK | Shattuck Labs, Inc. | 590.14M | 1.29% | 11,835 | 1.00M |
| 208 | DBVT | DBV Technologies S.A. | 584.96M | -6.95% | 98,931 | 3.76M |
| 209 | CBIO | Crescent Biopharma, Inc. | 580.81M | 0.52% | 4,651 | 11.88M |
| 210 | ETRA | Electra Therapeutics, Inc. | 563.65M | - | 1,792 | - |
| 211 | PBYI | Puma Biotechnology, Inc. | 548.21M | - | 4,422 | 231.24M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 546.50M | - | 173 | - |
| 213 | VALN | Valneva SE | 541.12M | - | 501 | 163.30M |
| 214 | ENTX | Entera Bio Ltd. | 539.16M | - | 8,060 | 42.00K |
| 215 | DMAC | DiaMedica Therapeutics Inc. | 532.25M | 0.51% | 2,977 | - |
| 216 | MDXG | MiMedx Group, Inc. | 532.03M | -7.59% | 158,816 | 303.73M |
| 217 | SRZN | Surrozen, Inc. | 530.98M | - | 1,065 | 11.51M |
| 218 | PHAT | Phathom Pharmaceuticals, Inc. | 524.24M | 5.10% | 115,328 | 239.66M |
| 219 | BLSM | BlossomHill Therapeutics, Inc. | 523.18M | - | 511 | - |
| 220 | INDP | Indaptus Therapeutics, Inc. | 522.18M | 2.10% | 792 | - |
| 221 | CTMX | CytomX Therapeutics, Inc. | 518.60M | 0.85% | 17,380 | 18.30M |
| 222 | ARVN | Arvinas, Inc. | 506.74M | 1.97% | 17,763 | 316.70M |
| 223 | FTH | Faeth Therapeutics, Inc. | 503.11M | 1.41% | 4,928 | - |
| 224 | OCS | Oculis Holding AG | 501.88M | 1.88% | 3,671 | 1.45M |
| 225 | MNPR | Monopar Therapeutics Inc. | 499.39M | 1.38% | 9,296 | - |
| 226 | OVID | Ovid Therapeutics Inc. | 490.20M | 2.45% | 60,360 | 1.58M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 489.27M | 1.36% | 9,769 | - |
| 228 | RGNX | REGENXBIO Inc. | 488.50M | 2.21% | 31,916 | 174.48M |
| 229 | PRTA | Prothena Corporation plc | 473.84M | 1.43% | 8,267 | 54.53M |
| 230 | ALLO | Allogene Therapeutics, Inc. | 466.41M | 3.85% | 258,930 | 4.64M |
| 231 | PROK | ProKidney Corp. | 456.51M | -0.66% | 36,492 | 818.00K |
| 232 | EDIT | Editas Medicine, Inc. | 454.60M | 0.34% | 148,934 | 47.01M |
| 233 | RZLT | Rezolute, Inc. | 453.15M | 2.37% | 16,752 | - |
| 234 | MPLT | MapLight Therapeutics, Inc. | 452.39M | 2.01% | 6,652 | - |
| 235 | YDES | YD Bio Limited | 444.82M | - | 2,672 | 1.24M |
| 236 | AUTL | Autolus Therapeutics plc | 436.51M | 0.61% | 32,036 | 117.39M |
| 237 | ZURA | Zura Bio Limited | 421.91M | 0.69% | 118,052 | - |
| 238 | CCCC | C4 Therapeutics, Inc. | 420.75M | 0.74% | 25,661 | 35.04M |
| 239 | ASMB | Assembly Biosciences, Inc. | 418.82M | - | 1,311 | 74.85M |
| 240 | PRLD | Prelude Therapeutics Incorporated | 418.16M | -1.93% | 4,277 | 22.42M |
| 241 | NAUT | Nautilus Biotechnology, Inc. | 416.51M | 1.87% | 432,981 | 424.00K |
| 242 | ALT | Altimmune, Inc. | 414.32M | 1.43% | 153,678 | 31.00K |
| 243 | TECX | Tectonic Therapeutic, Inc. | 401.93M | - | 3,810 | - |
| 244 | AGMB | AgomAb Therapeutics NV | 392.01M | - | 2,260 | - |
| 245 | TRXB | TRex Bio, Inc. | 388.48M | - | 413 | - |
| 246 | AVTX | Avalo Therapeutics, Inc. | 382.92M | 0.28% | 22,491 | 59.00K |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 381.18M | - | 1,980 | 59.22M |
| 248 | SPRY | ARS Pharmaceuticals, Inc. | 378.89M | 4.38% | 18,081 | 116.93M |
| 249 | KYTX | Kyverna Therapeutics, Inc. | 372.30M | 2.21% | 21,844 | - |
| 250 | GALT | Galectin Therapeutics Inc. | 369.11M | 3.39% | 3,423 | - |
| 251 | CAPR | Capricor Therapeutics, Inc. | 366.28M | 1.12% | 83,430 | 11.13M |
| 252 | CTNM | Contineum Therapeutics, Inc. | 363.83M | 5.69% | 6,455 | - |
| 253 | OBIO | Orchestra BioMed Holdings, Inc. | 358.83M | -0.33% | 6,492 | 31.98M |
| 254 | RLMD | Relmada Therapeutics, Inc. | 357.34M | - | 3,001 | - |
| 255 | ARCT | Arcturus Therapeutics Holdings Inc. | 348.18M | 1.49% | 8,553 | 29.37M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 342.47M | - | 2,812 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 337.10M | 1.49% | 10,895 | 15.85M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 336.40M | - | 1,231 | 65.26M |
| 259 | ALEC | Alector, Inc. | 335.06M | 0.44% | 106,952 | 13.86M |
| 260 | SCTX | Scribe Therapeutics Inc. | 331.59M | -0.14% | 7,689 | 33.30M |
| 261 | TTRX | Turn Therapeutics Inc. | 331.24M | - | 1,473 | - |
| 262 | AGEN | Agenus Inc. | 323.70M | 0.84% | 25,262 | 132.69M |
| 263 | VTVT | vTv Therapeutics Inc. | 319.57M | - | 499 | 36.84M |
| 264 | IRD | Opus Genetics, Inc. | 315.31M | 2.99% | 15,878 | 9.86M |
| 265 | EIKN | Eikon Therapeutics, Inc. | 309.55M | 3.16% | 7,414 | - |
| 266 | BNTC | Benitec Biopharma Inc. | 304.53M | -0.80% | 2,264 | - |
| 267 | SABS | SAB Biotherapeutics, Inc. | 296.62M | 1.87% | 5,904 | 114.70K |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 294.96M | - | 2,835 | 1.00 |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 287.64M | 0.53% | 88,653 | 80.00M |
| 270 | RCKT | Rocket Pharmaceuticals, Inc. | 287.61M | 1.55% | 25,183 | - |
| 271 | VOGX | Vogenx, Inc. | 281.06M | - | 1,112 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 280.67M | 3.35% | 14,425 | 61.21M |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 276.44M | 2.51% | 3,844 | 412.09K |
| 274 | VNDA | Vanda Pharmaceuticals Inc. | 275.71M | 14.00% | 137,092 | 229.28M |
| 275 | QTTB | Q32 Bio Inc. | 271.65M | 0.72% | 6,296 | 53.74M |
| 276 | IPSC | Century Therapeutics, Inc. | 271.61M | - | 5,553 | 109.16M |
| 277 | LRMR | Larimar Therapeutics, Inc. | 271.40M | 2.36% | 25,208 | - |
| 278 | LYEL | Lyell Immunopharma, Inc. | 267.84M | - | 602 | 27.00K |
| 279 | OCGN | Ocugen, Inc. | 266.51M | 1.22% | 133,746 | 4.58M |
| 280 | CABA | Cabaletta Bio, Inc. | 266.19M | 3.29% | 198,872 | - |
| 281 | LCTX | Lineage Cell Therapeutics, Inc. | 265.55M | 0.96% | 36,312 | 13.08M |
| 282 | FATE | Fate Therapeutics, Inc. | 263.61M | 1.38% | 37,881 | 6.49M |
| 283 | GLSI | Greenwich LifeSciences, Inc. | 262.74M | -2.24% | 988 | - |
| 284 | LXEO | Lexeo Therapeutics, Inc. | 262.54M | 2.24% | 13,439 | - |
| 285 | ABEO | Abeona Therapeutics Inc. | 261.90M | 0.66% | 38,252 | 25.52M |
| 286 | CUVL | Clinuvel Pharmaceuticals Limited | 260.22M | - | 1,010 | 65.05M |
| 287 | IMRX | Immuneering Corporation | 258.79M | 0.25% | 21,301 | - |
| 288 | IFRX | InflaRx N.V. | 254.95M | - | 4,791 | -11.54K |
| 289 | PYXS | Pyxis Oncology, Inc. | 243.79M | 3.07% | 27,661 | 11.04M |
| 290 | ACIU | AC Immune SA | 235.64M | - | 5,459 | 21.67M |
| 291 | EVMN | Evommune, Inc. | 234.45M | 2.38% | 33,467 | 10.00M |
| 292 | KROS | Keros Therapeutics, Inc. | 232.18M | 0.86% | 1,062 | 15.01M |
| 293 | CAMP | Camp4 Therapeutics Corporation | 228.42M | -0.27% | 1,377 | 4.22M |
| 294 | ELDN | Eledon Pharmaceuticals, Inc. | 224.50M | - | 63,799 | - |
| 295 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 224.49M | - | 2,791 | - |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 224.01M | 0.35% | 1,084 | 1.80M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 208.68M | - | 3,604 | 80.62M |
| 298 | KRRO | Korro Bio, Inc. | 208.22M | 2.02% | 4,231 | 2.38M |
| 299 | DTIL | Precision BioSciences, Inc. | 206.18M | - | 2,443 | 45.06M |
| 300 | ARTV | Artiva Biotherapeutics, Inc. | 205.83M | -1.52% | 166,980 | 251.00K |
| 301 | PALI | Palisade Bio, Inc. | 204.77M | -1.26% | 277,470 | 500.00K |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 202.41M | - | 500 | 1.48M |
| 303 | ACOG | Alpha Cognition Inc. | 199.70M | - | 879 | 15.26M |
| 304 | PRQR | ProQR Therapeutics N.V. | 198.98M | - | 6,316 | 21.05M |
| 305 | ZNTL | Zentalis Pharmaceuticals, Inc. | 198.81M | 1.94% | 106,844 | 26.87M |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 197.25M | - | 2,240 | 7.15M |
| 307 | CGEN | Compugen Ltd. | 190.40M | - | 1,440 | 74.00M |
| 308 | IVVD | Invivyd, Inc. | 182.49M | 0.41% | 75,461 | 58.37M |
| 309 | YARW | Yarrow Bioscience, Inc. | 182.09M | - | 439 | - |
| 310 | ADAG | Adagene Inc. | 180.62M | 0.75% | 17,417 | 9.29M |
| 311 | SION | Sionna Therapeutics, Inc. | 180.10M | -1.40% | 7,760 | - |
| 312 | MDWD | MediWound Ltd. | 177.52M | 1.40% | 3,303 | 11.86M |
| 313 | PEPG | PepGen Inc. | 175.23M | - | 2,490 | - |
| 314 | ABOS | Acumen Pharmaceuticals, Inc. | 175.03M | 1.68% | 46,012 | - |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 174.71M | 0.96% | 11,175 | 2.00M |
| 316 | TRDA | Entrada Therapeutics, Inc. | 171.63M | -1.65% | 2,403 | 4.69M |
| 317 | ANTX | AN2 Therapeutics, Inc. | 170.57M | - | 4,630 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 169.32M | 4.17% | 95,305 | 1.50M |
| 319 | ALXO | ALX Oncology Holdings Inc. | 163.17M | - | 27,087 | - |
| 320 | UPB | Upstream Bio, Inc. | 162.94M | -0.17% | 8,406 | 3.16M |
| 321 | CHRS | Coherus Oncology, Inc. | 162.23M | -9.48% | 238,769 | 50.94M |
| 322 | NGEN | NervGen Pharma Corp. | 161.28M | - | 8,605 | - |
| 323 | MGNX | MacroGenics, Inc. | 157.34M | - | 6,852 | 175.14M |
| 324 | STRO | Sutro Biopharma, Inc. | 154.04M | - | 2,765 | 45.70M |
| 325 | CUE | Cue Biopharma, Inc. | 153.72M | - | 2,794 | 37.66M |
| 326 | MENS | Jyong Biotech Ltd. | 152.18M | - | 1,818 | - |
| 327 | NBP | NovaBridge Biosciences | 146.16M | - | 9,928 | - |
| 328 | RNA | Atrium Therapeutics, Inc. | 144.37M | 0.48% | 3,627 | 35.84M |
| 329 | VRXA | Veraxa Biotech AG | 141.41M | 2.04% | 1,719 | 29.54K |
| 330 | CMPX | Compass Therapeutics, Inc. | 140.47M | 2.59% | 19,542 | 850.00K |
| 331 | CDXS | Codexis, Inc. | 139.62M | 1.19% | 60,987 | 77.68M |
| 332 | TARA | Protara Therapeutics, Inc. | 138.88M | -5.62% | 3,363 | - |
| 333 | MOLN | Molecular Partners AG | 138.54M | - | 201 | 856.30K |
| 334 | HUMA | Humacyte, Inc. | 137.32M | 5.15% | 350,148 | 2.12M |
| 335 | MSLE | Satellos Bioscience Inc. | 136.50M | - | 498 | - |
| 336 | SPRB | Spruce Biosciences, Inc. | 135.05M | - | 1,110 | 697.00K |
| 337 | IPHA | Innate Pharma S.A. | 133.47M | - | 1,002 | 11.21M |
| 338 | HURA | TuHURA Biosciences, Inc. | 129.37M | 2.01% | - | - |
| 339 | FHTX | Foghorn Therapeutics Inc. | 126.49M | - | 5,478 | 36.74M |
| 340 | NKTX | Nkarta, Inc. | 123.91M | 0.58% | 24,331 | - |
| 341 | KZIA | Kazia Therapeutics Limited | 123.20M | 7.92% | - | 1.27M |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 122.33M | - | 489 | 5.54M |
| 343 | OTLK | Outlook Therapeutics, Inc. | 121.70M | -8.26% | 287,139 | -1.16M |
| 344 | TLSA | Tiziana Life Sciences Ltd | 121.63M | - | 6,222 | - |
| 345 | AVXL | Anavex Life Sciences Corp. | 120.51M | - | 20,120 | - |
| 346 | ANIX | Anixa Biosciences, Inc. | 118.89M | 1.48% | 6,619 | - |
| 347 | PDSB | PDS Biotechnology Corporation | 118.86M | 7.89% | 734,060 | - |
| 348 | PYPD | PolyPid Ltd. | 117.40M | - | 6,870 | - |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 116.81M | 0.37% | 29,024 | 3.39M |
| 350 | VYGR | Voyager Therapeutics, Inc. | 115.84M | 2.17% | 15,723 | 34.46M |
| 351 | EQ | Equillium, Inc. | 111.28M | - | 249 | 4.39M |
| 352 | NERV | Minerva Neurosciences, Inc. | 109.34M | 3.62% | 658 | - |
| 353 | ENGN | enGene Therapeutics Inc. | 109.24M | 3.16% | 5,887 | - |
| 354 | IMUX | Immunic, Inc. | 109.16M | 0.25% | 4,650 | - |
| 355 | CBUS | Cibus, Inc. | 107.76M | - | 1,796 | 4.35M |
| 356 | TENX | Tenax Therapeutics, Inc. | 107.69M | - | 433,333 | - |
| 357 | MIST | Milestone Pharmaceuticals Inc. | 107.04M | 0.29% | 6,772 | 2.34M |
| 358 | OKUR | OnKure Therapeutics, Inc. | 106.51M | - | 2,394 | - |
| 359 | UNCY | Unicycive Therapeutics, Inc. | 104.74M | - | 9,600 | - |
| 360 | RTSN | Retension Pharmaceuticals, Inc. | 104.23M | -4.43% | 362 | - |
| 361 | PMVP | PMV Pharmaceuticals, Inc. | 104.21M | - | 3,363 | - |
| 362 | LENZ | LENZ Therapeutics, Inc. | 103.69M | 2.80% | 98,377 | 12.36M |
| 363 | SEER | Seer, Inc. | 103.55M | -6.03% | 1,112 | 14.22M |
| 364 | VANI | Vivani Medical, Inc. | 102.83M | - | 2,205 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 101.85M | -3.13% | 8,489 | 70.00M |
| 366 | PMN | ProMIS Neurosciences, Inc. | 99.27M | - | 1,076 | - |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 98.75M | 2.85% | 300,829 | 65.34K |
| 368 | TVGN | Tevogen Inc. | 98.20M | - | 183 | - |
| 369 | GNLX | Genelux Corporation | 96.79M | -2.26% | 7,321 | 8.00K |
| 370 | ICCC | ImmuCell Corporation | 96.45M | - | 1,683 | 30.68M |
| 371 | COYA | Coya Therapeutics, Inc. | 95.24M | - | 238 | 8.02M |
| 372 | NRXS | NeurAxis, Inc. | 95.06M | - | 2,638 | 5.32M |
| 373 | TNXP | Tonix Pharmaceuticals Holding Corp. | 93.64M | 1.68% | 22,763 | 29.10M |
| 374 | TNYA | Tenaya Therapeutics, Inc. | 91.73M | 1.31% | 61,201 | 1.34M |
| 375 | PLYX | Polaryx Therapeutics, Inc. | 91.22M | -3.17% | 2,085 | - |
| 376 | CNXU | Conexeu Sciences Inc. | 90.95M | 2.43% | 49,408 | - |
| 377 | CLLS | Cellectis S.A. | 88.50M | -3.17% | 2,134 | 63.82M |
| 378 | ATRA | Atara Biotherapeutics, Inc. | 86.93M | - | 204 | 6.19M |
| 379 | RLYB | Rallybio Corporation | 84.91M | - | 2,018 | 434.00K |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 83.78M | -2.32% | 6,386 | 4.88M |
| 381 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 82.97M | 0.94% | 17,094 | - |
| 382 | OKYO | OKYO Pharma Limited | 78.19M | - | 213 | - |
| 383 | NTRB | Nutriband Inc. | 77.80M | - | 541 | 1.62M |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 77.14M | 0.56% | 21,945 | - |
| 385 | CING | Cingulate Inc. | 75.04M | -1.71% | 2,158 | - |
| 386 | NTHI | NeOnc Technologies Holdings, Inc. | 73.58M | -2.31% | 1,884 | 39.99K |
| 387 | NMRA | Neumora Therapeutics, Inc. | 73.26M | -0.81% | 31,965 | - |
| 388 | MNOV | MediciNova, Inc. | 72.36M | - | 1,433 | 920.48K |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 72.10M | -3.03% | 12,397 | - |
| 390 | CGTX | Cognition Therapeutics, Inc. | 71.23M | - | 5,710 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 71.17M | 0.86% | 26,499 | - |
| 392 | CRDF | Cardiff Oncology, Inc. | 69.83M | - | 1,775 | 508.00K |
| 393 | CSBR | Champions Oncology, Inc. | 68.48M | - | 53 | 60.66M |
| 394 | SPRO | Spero Therapeutics, Inc. | 68.13M | - | 4,318 | 47.00M |
| 395 | FBIO | Fortress Biotech, Inc. | 67.70M | 3.57% | 23,025 | 68.47M |
| 396 | GOSS | Gossamer Bio, Inc. | 66.79M | 2.15% | 5,261 | 53.29M |
| 397 | RNXT | RenovoRx, Inc. | 64.31M | - | 8,482 | 1.98M |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 62.19M | 4.02% | 1,614 | 30.32M |
| 399 | RNTX | Rein Therapeutics Inc. | 61.66M | - | 10,199 | - |
| 400 | XBIT | XBiotech Inc. | 60.67M | - | 2,004 | - |
| 401 | PTHS | Pelthos Therapeutics Inc. | 60.26M | - | 1,768 | 43.30M |
| 402 | OSTX | OS Therapies Incorporated | 59.61M | 3.20% | 3,894 | - |
| 403 | HRTX | Heron Therapeutics, Inc. | 58.85M | 0.36% | 6,161 | 151.18M |
| 404 | CLNN | Clene Inc. | 57.28M | - | 1,029 | 197.00K |
| 405 | BOLD | Boundless Bio, Inc. | 56.87M | - | 1,588 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 56.77M | 2.12% | 18,660 | 11.57M |
| 407 | ONCY | Oncolytics Biotech Inc. | 56.27M | -0.07% | 43,098 | - |
| 408 | INKT | MiNK Therapeutics, Inc. | 55.11M | - | 339 | - |
| 409 | PLRX | Pliant Therapeutics, Inc. | 55.10M | - | 2,601 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 54.05M | 2.06% | 282 | - |
| 411 | ALPS | Alps Group Inc | 53.91M | -0.31% | 123 | 3.74M |
| 412 | CNTB | Connect Biopharma Holdings Limited | 53.09M | -0.27% | 8,072 | 2.95M |
| 413 | HOWL | Werewolf Therapeutics, Inc. | 52.97M | 2.83% | 20,523 | 21.00M |
| 414 | CRBU | Caribou Biosciences, Inc. | 52.80M | 0.63% | 72,532 | 10.04M |
| 415 | XLO | Xilio Therapeutics, Inc. | 52.71M | - | 24 | 64.09M |
| 416 | GANX | Gain Therapeutics, Inc. | 52.59M | 0.84% | 11,853 | - |
| 417 | IBIO | iBio, Inc. | 52.29M | 1.11% | 6,424 | 100.00K |
| 418 | HYPD | Hyperion DeFi, Inc. | 52.06M | 11.67% | 75,487 | 1.40M |
| 419 | MREO | Mereo BioPharma Group plc | 49.41M | 4.18% | 14,724 | 500.00K |
| 420 | ELTX | Elicio Therapeutics, Inc. | 48.62M | - | 11,354 | - |
| 421 | KLRS | Kalaris Therapeutics, Inc. | 47.85M | - | 56 | - |
| 422 | IMA | ImageneBio, Inc. | 47.68M | - | - | 800.00K |
| 423 | BMEA | Biomea Fusion, Inc. | 47.04M | 0.20% | 10,656 | - |
| 424 | LONA | LeonaBio, Inc. | 46.73M | - | 1,687 | - |
| 425 | TIL | Instil Bio, Inc. | 46.05M | - | 1,564 | - |
| 426 | APLM | Apollomics, Inc. | 43.86M | - | 50 | 8.84M |
| 427 | ANVS | Annovis Bio, Inc. | 42.18M | -2.93% | 33,427 | - |
| 428 | ATHE | Alterity Therapeutics Limited | 41.93M | - | 262 | 2.50M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 41.81M | -0.81% | 3,229 | - |
| 430 | SER | Serina Therapeutics, Inc. | 41.66M | - | 6,634 | 130.00K |
| 431 | INMB | INmune Bio Inc. | 41.63M | -1.96% | 5,445 | 50.00K |
| 432 | ALDX | Aldeyra Therapeutics, Inc. | 41.26M | 0.06% | 40,990 | - |
| 433 | ACET | Adicet Bio, Inc. | 41.01M | - | 947 | - |
| 434 | GRDX | GridAI Technologies Corp. | 40.79M | - | 126 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 39.97M | -5.47% | 1,005 | - |
| 436 | EXOZ | eXoZymes, Inc. | 39.21M | - | 4 | -700.00 |
| 437 | VERU | Veru Inc. | 38.70M | - | 1,907 | 16.89M |
| 438 | NNVC | NanoViricides, Inc. | 37.01M | - | 10,176 | - |
| 439 | LITS | Lite Strategy, Inc. | 36.79M | -1.63% | 16,068 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 36.16M | -16.67% | 2,737 | 35.09M |
| 441 | ESLA | Estrella Immunopharma, Inc. | 34.81M | -2.62% | 20,507 | - |
| 442 | EDSA | Edesa Biotech, Inc. | 34.59M | - | 770 | - |
| 443 | IRLA | IRulya Therapeutics Inc. | 33.52M | - | 676 | - |
| 444 | CRVO | CervoMed Inc. | 33.41M | - | - | 331.30K |
| 445 | IBO | Impact BioMedical Inc. | 33.41M | -2.00% | 674 | 35.00K |
| 446 | EYPT | EyePoint, Inc. | 33.17M | 1.96% | 167,328 | 2.79M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.28M | - | 105 | 31.52M |
| 448 | FLNA | Filana Therapeutics, Inc. | 31.75M | 1.00% | 3,104 | - |
| 449 | AARD | Aardvark Therapeutics, Inc. | 31.73M | -3.97% | 61,084 | - |
| 450 | RNAZ | TransCode Therapeutics, Inc. | 31.15M | 5.75% | 386 | - |
| 451 | MGX | Metagenomi Therapeutics, Inc. | 31.04M | - | 2,362 | 13.56M |
| 452 | BCTX | BriaCell Therapeutics Corp. | 30.38M | 0.86% | 631 | - |
| 453 | CELU | Celularity Inc. | 29.53M | -3.20% | 151,898 | 18.67M |
| 454 | BSEM | BioStem Technologies, Inc. | 28.73M | 2.39% | 21,537 | 34.59M |
| 455 | ABVC | ABVC BioPharma, Inc. | 28.30M | - | 1,441 | 797.92K |
| 456 | CVM | CEL-SCI Corporation | 28.14M | - | 3,971 | - |
| 457 | NXTC | NextCure, Inc. | 27.46M | -5.36% | 532 | - |
| 458 | EVAX | Evaxion A/S | 25.94M | - | 1,121 | 7.49M |
| 459 | IMMP | Immutep Limited | 23.83M | -0.15% | 385 | 13.79M |
| 460 | IGC | IGC Pharma, Inc. | 23.78M | -3.64% | 145,772 | 1.11M |
| 461 | ATOS | Atossa Therapeutics, Inc. | 23.65M | - | 8,212 | - |
| 462 | BYSI | BeyondSpring Inc. | 21.57M | - | 1,467 | 1.88M |
| 463 | AKTX | Akari Therapeutics, Plc | 21.02M | - | 28 | - |
| 464 | PLRZ | Polyrizon Ltd. | 20.91M | - | 67 | - |
| 465 | KPTI | Karyopharm Therapeutics Inc. | 20.25M | 7.32% | 797,634 | 146.62M |
| 466 | QNTM | Quantum BioPharma Ltd. | 19.98M | -0.42% | 3,563 | - |
| 467 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.75M | - | 30 | - |
| 468 | KYNB | Kyntra Bio, Inc. | 19.11M | - | 64 | 4.62M |
| 469 | COCP | Cocrystal Pharma, Inc. | 19.07M | - | 15 | 330.00K |
| 470 | CNTX | Context Therapeutics Inc. | 18.63M | -4.02% | 33,574 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 18.18M | - | 4,612 | 1.17M |
| 472 | MCRB | Seres Therapeutics, Inc. | 17.98M | - | 349 | 1.88M |
| 473 | JSPR | Jasper Therapeutics, Inc. | 17.01M | -5.14% | 2,069 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 16.67M | - | 4,483 | 3.55M |
| 475 | NCEL | NewcelX Ltd. | 15.60M | - | 233 | - |
| 476 | PLUR | Pluri Inc. | 15.18M | - | 1,030 | 1.02M |
| 477 | ALLR | Allarity Therapeutics, Inc. | 15.12M | - | 130 | 345.00K |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 14.86M | 0.02% | 70,506 | 7.11M |
| 479 | DYAI | Dyadic International, Inc. | 14.36M | - | 457 | 3.80M |
| 480 | BCDA | BioCardia, Inc. | 14.34M | - | 56 | 3.00K |
| 481 | KPRX | Kiora Pharmaceuticals, Inc. | 13.87M | -7.63% | 63,492 | 20.00K |
| 482 | RADX | Radiopharm Theranostics Limited | 13.74M | - | 8 | 8.90M |
| 483 | PBM | Psyence Biomedical Ltd. | 13.54M | 4.41% | 805 | - |
| 484 | TCRX | TScan Therapeutics, Inc. | 13.48M | - | 9,600 | 7.11M |
| 485 | CNSY | Cerenome, Inc. | 13.36M | 1.15% | 509 | 4.20M |
| 486 | AEON | AEON Biopharma, Inc. | 13.05M | -0.91% | 29,110 | - |
| 487 | ICU | SeaStar Medical Holding Corporation | 13.05M | - | 3,612 | 1.71M |
| 488 | DARE | Daré Bioscience, Inc. | 12.83M | -4.10% | 1,481 | 1.37M |
| 489 | ADIL | Adial Pharmaceuticals, Inc. | 12.74M | -3.96% | - | - |
| 490 | BOLT | Bolt Biotherapeutics, Inc. | 12.48M | -1.52% | 2,587 | 4.70M |
| 491 | KTTA | Pasithea Therapeutics Corp. | 12.33M | -6.11% | 10,446 | - |
| 492 | LPCN | Lipocine Inc. | 12.28M | -1.32% | 5,080 | 1.57M |
| 493 | ATYR | aTyr Pharma, Inc. | 12.26M | -2.65% | 6,112 | 190.00K |
| 494 | HIND | Vyome Holdings, Inc. | 12.07M | - | 256 | 129.73K |
| 495 | TVRD | Tvardi Therapeutics, Inc. | 11.60M | -1.94% | 6,839 | - |
| 496 | GUTS | Fractyl Health, Inc. | 11.45M | -3.01% | 42,864 | 3.00K |
| 497 | CLRB | Cellectar Biosciences, Inc. | 11.44M | -2.42% | 1,851 | - |
| 498 | CALC | CalciMedica, Inc. | 11.27M | -0.60% | 19,581 | - |
| 499 | GDTC | CytoMed Therapeutics Limited | 11.16M | - | 1,691 | 609.73K |
| 500 | INTS | Intensity Therapeutics, Inc. | 11.04M | - | 710 | - |